Evidence map›Paper›PMID 35054912›Full record

ArticleInternational journal of molecular sciences2022

Exploring the Bioactive Potentials of C

Kunal Biswas, Awdhesh Kumar Mishra, Pradipta Ranjan Rauta, Abdullah G Al-Sehemi, Mehboobali Pannipara, Avik Sett, Amra Bratovcic, Satya Kumar Avula, Tapan Kumar Mohanta, Muthupandian Saravanan and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kunal BiswasCentre for Nanoscience and Nanotechnology, Sathyabama Institute of Science and Technology (Formerly Sathyabama University), Jeppiar Nagar, Salai, Chennai 600119, India.
Awdhesh Kumar MishraDepartment of Biotechnology, Yeungnam University, Gyeongsan 38541, Gyeongsangbuk-do, Korea.ORCID 0000-0002-3312-3264
Pradipta Ranjan RautaDepartment of Biological Sciences, Asian Institute of Public Health University, Bhubaneswar 751002, India.ORCID 0000-0002-2874-0209
Abdullah G Al-SehemiDepartment of Chemistry, King Khalid University, Abha 61413, Saudi Arabia.ORCID 0000-0002-6793-3038
Mehboobali PanniparaDepartment of Chemistry, King Khalid University, Abha 61413, Saudi Arabia.
Avik SettDepartment of Electronics and Electrical Communication Engineering, Indian Institute of Technology Kharagpur, Kharagpur 721302, India.
Amra BratovcicDepartment of Physical Chemistry and Electrochemistry, Faculty of Technology, University of Tuzla, Univerzitetska 8, 75000 Tuzla, Bosnia and Herzegovina.
Satya Kumar AvulaNatural and Medical Sciences Research Centre, University of Nizwa, Nizwa 616, Oman.ORCID 0000-0003-3941-7164
Tapan Kumar MohantaNatural and Medical Sciences Research Centre, University of Nizwa, Nizwa 616, Oman.ORCID 0000-0002-3196-7746
Muthupandian SaravananDepartment of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Chennai 600077, India.ORCID 0000-0002-1480-3555
Yugal Kishore MohantaDepartment of Applied Biology, University of Science and Technology Meghalaya, Ri-Bhoi 793101, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At present, the potential role of the AgNPs/endo-fullerene molecule metal nano-composite has been evaluated over the biosystems in-vitro. The intra-atomic configuration of the fullerene molecule (C

Indexed as

Anti-Infective AgentsAntineoplastic AgentsAntioxidantsCell Line, TumorCell SurvivalFullerenesHumansMetal NanoparticlesNanocompositesSilverSpectrum AnalysisAnti-Infective AgentsAntineoplastic AgentsAntioxidantsfullerene C60FullerenesSilverAgNPsantimicrobialsantioxidantsbreast adenocarcinomafullerenein-vitro

Identifiers

PMID35054912
PMCPMC8776077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.